Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Stemline Therapeutic (NQ: STML )

11.83 USD UNCHANGED
Last Price Updated: 9:18 AM EDT, Jun 10, 2020 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Stemline Therapeutic

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Menarini Group Completes Acquisition of Stemline Therapeutics
Menarini Group, a privately held Italian pharmaceutical and diagnostics company, today announced that is has successfully completed the acquisition of Stemline Therapeutics Inc., a commercial-stage... 
From Business Wire News Releases
Lifshitz Law Firm, P.C. Announces Investigation of Franklin Financial Network, Inc., Mobile Mini, Inc., Portola Pharmaceuticals, Inc., resTORbio, Inc., Stemline Therapeutics, Inc., Taubman Centers, In
From PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, and QES Shareholders About Its Ongoing Investigations
From GlobeNewswire News Releases
STEMLINE ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of STML and Encourages Investors to Contact the Firm
From GlobeNewswire News Releases
KLXE, FSB, PTLA, and STML SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
From GlobeNewswire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA
From ACCESSWIRE
Lifshitz Law Firm, P.C. Announces Investigation of KLX Energy Services Holdings, Inc. (KLXE), Quintana Energy Services, Inc. (QES), Portola Pharmaceuticals, Inc. (PTLA), and Stemline Therapeutics, Inc
From GlobeNewswire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm
Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration,... 
From PR Newswire
SHAREHOLDER ALERT: WeissLaw LLP Reminds STML, PTLA, QES, and TERP Shareholders About Its Ongoing Investigations
From GlobeNewswire News Releases
INVESTIGATION ALERT: Halper Sadeh LLP Investigates Whether the Following Mergers are Fair to Shareholders; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA
From ACCESSWIRE
KLXE, PTLA, STML, and TORC SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
From GlobeNewswire News Releases
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA
From ACCESSWIRE
Lifshitz Law Firm, P.C. Announces Investigation of KLX Energy Services Holdings, Inc. (KLXE), Portola Pharmaceuticals, Inc. (PTLA), Stemline Therapeutics, Inc. (STML) and Zuora, Inc. (ZUO)
From GlobeNewswire News Releases
Shareholder Alert: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA
From ACCESSWIRE
KLXE, PTLA, and STML SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
From GlobeNewswire News Releases
Shareholder Investigation: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - STML, KLXE, PTLA
From ACCESSWIRE
SHAREHOLDER ALERT: WeissLaw LLP Investigates Stemline Therapeutics, Inc.
WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Directors of Stemline Therapeutics, Inc. ("STML" or the "Company") (NASDAQ: STML) in... 
From PR Newswire
Moore Kuehn Encourages TORC, STML, KLXE, and PTLA Investors to Contact Law Firm
Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are... 
From PR Newswire
Shareholder Investigation: Halper Sadeh LLP Investigates the Following Companies; Investors are Encouraged to Contact the Firm - TORC, STML, KLXE
From ACCESSWIRE
SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Stemline Therapeutics, Inc. - STML
Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating Stemline... 
From PR Newswire
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Stemline Therapeutics Inc.
Rowley Law PLLC is investigating potential securities law violations by Stemline Therapeutics Inc. (NASDAQ: STML) and its board of directors concerning the proposed acquisition of the company by... 
From PR Newswire
SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Sale of These Companies; Investors are Encouraged to Contact the Firm - TERP, TORC, STML
From ACCESSWIRE
Stemline Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether The Sale Of Stemline Therapeutics, Inc. Is Fair To Shareholders; Investors Are Encouraged To Contact The Firm
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Stemline Therapeutics, Inc. (NASDAQ: STML) to Menarini Group is fair to Stemline shareholders. On behalf of... 
From PR Newswire
Shareholder Alert: Ademi & O'Reilly, LLP Investigates whether Stemline Therapeutics Inc. has obtained a Fair Price in its sale to Menarini Group
Ademi & O'Reilly, LLP is investigating Stemline (Nasdaq: STML) for possible breaches of fiduciary duty and other violations of the law in connection with the sale to Menarini. 
From PR Newswire
Thinking about buying stock in Stemline Therapeutics, KLX Energy, Trinity Biotech, Tilray, or Ritter Pharmaceuticals?
InvestorsObserver issues critical PriceWatch Alerts for STML, KLXE, TRIB, TLRY, and RTTR. 
From PR Newswire
(STML) Alert: Johnson Fistel Investigates Proposed Sale of Stemline Therapeutics; Are Shareholders Getting a Fair Deal?
From PR Newswire
Menarini Group to Acquire Stemline Therapeutics in Transaction Valued at Up to $677 Million
From GlobeNewswire News Releases
Stemline Therapeutics Reports Fourth Quarter 2019 Financial Results
From GlobeNewswire News Releases
Stemline Therapeutics to Host Conference Call on Fourth Quarter 2019 Financial Results on March 16, 2020
From GlobeNewswire News Releases
Stemline Therapeutics to Present at the Cowen 40th Annual Health Care Conference
From GlobeNewswire News Releases
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]